Great Point Partners Has Decreased Biocryst Pharmaceuticals (Call) (BCRX) Holding; Redwood Capital Management Lowered Humana (HUM) Holding

August 29, 2017 - By Winifred Garcia

Great Point Partners Llc decreased Biocryst Pharmaceuticals (Call) (BCRX) stake by 31.03% reported in 2016Q4 SEC filing. Great Point Partners Llc sold 225,000 shares as Biocryst Pharmaceuticals (Call) (BCRX)’s stock declined 16.46%. The Great Point Partners Llc holds 500,000 shares with $3.17 million value, down from 725,000 last quarter. Biocryst Pharmaceuticals (Call) now has $405.36 million valuation. The stock rose 2.02% or $0.1 reaching $5.04. About 445,466 shares traded. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has risen 75.08% since August 29, 2016 and is uptrending. It has outperformed by 58.38% the S&P500.

Redwood Capital Management Llc decreased Humana Inc (HUM) stake by 12.38% reported in 2016Q4 SEC filing. Redwood Capital Management Llc sold 10,000 shares as Humana Inc (HUM)’s stock rose 11.38%. The Redwood Capital Management Llc holds 70,770 shares with $14.44 million value, down from 80,770 last quarter. Humana Inc now has $36.80 billion valuation. The stock declined 0.17% or $0.44 reaching $254.63 per share. About 427,086 shares traded. Humana Inc (NYSE:HUM) has risen 35.38% since August 29, 2016 and is uptrending. It has outperformed by 18.68% the S&P500.

Since March 6, 2017, it had 0 insider buys, and 4 insider sales for $139,783 activity. 3,250 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares with value of $25,675 were sold by STAAB THOMAS R II.

Investors sentiment increased to 1.68 in 2016 Q4. Its up 0.18, from 1.5 in 2016Q3. It is positive, as 14 investors sold BCRX shares while 23 reduced holdings. 19 funds opened positions while 32 raised stakes. 52.04 million shares or 2.90% more from 50.57 million shares in 2016Q3 were reported. Legal & General Public Ltd Liability Co holds 17,727 shares or 0% of its portfolio. Hap Trading Ltd Company holds 51,468 shares. Millennium Management Lc has 0% invested in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) for 186,994 shares. Art Advisors Limited Liability Corporation accumulated 14,300 shares. Dafna Cap Management Ltd Limited Liability Company has invested 0.37% of its portfolio in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Glenmede Tru Na reported 0% in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Schwab Charles Inv Mngmt reported 0% of its portfolio in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Fmr Limited Liability Corp reported 737,723 shares or 0% of all its holdings. Ra Limited Liability holds 2.76% or 2.99 million shares. Blackrock Gru reported 25,830 shares. Proshare Limited invested 0% in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Northern has 872,520 shares. Deutsche Commercial Bank Ag stated it has 0% in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). 1,801 are held by Zurcher Kantonalbank (Zurich Cantonalbank). D E Shaw Co holds 0.04% or 3.68M shares.

Among 11 analysts covering BioCryst Pharmaceuticals (NASDAQ:BCRX), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. BioCryst Pharmaceuticals had 24 analyst reports since August 7, 2015 according to SRatingsIntel. Noble Financial maintained the stock with “Buy” rating in Tuesday, August 8 report. The stock has “Market Perform” rating by JMP Securities on Thursday, August 4. H.C. Wainwright maintained the shares of BCRX in report on Tuesday, August 8 with “Buy” rating. The company was upgraded on Friday, August 12 by Piperjaffray. The stock has “Buy” rating by H.C. Wainwright on Friday, May 26. The rating was maintained by Rodman & Renshaw with “Buy” on Tuesday, February 9. The firm earned “Neutral” rating on Tuesday, February 9 by JP Morgan. The company was upgraded on Friday, August 12 by PiperJaffray. Ladenburg Thalmann initiated the stock with “Buy” rating in Thursday, February 16 report. The stock of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) earned “Buy” rating by Jefferies on Tuesday, February 9.

Great Point Partners Llc increased Enanta Pharmaceuticals Inc (NASDAQ:ENTA) stake by 38,253 shares to 828,253 valued at $27.75M in 2016Q4. It also upped Colucid Pharmaceuticals Inc stake by 37,865 shares and now owns 437,865 shares. Bovie Medical Corp (NYSEMKT:BVX) was raised too.

Since March 3, 2017, it had 0 buys, and 8 insider sales for $39.88 million activity. MURRAY JAMES E also sold $6.65 million worth of Humana Inc (NYSE:HUM) shares. On Friday, March 3 Zipperle Cynthia H sold $402,206 worth of Humana Inc (NYSE:HUM) or 1,885 shares. The insider BROUSSARD BRUCE D sold $26.70 million. The insider Dunbar Webster Roy sold 3,000 shares worth $639,360. 13,939 shares were sold by Huval Timothy S., worth $3.15 million. Another trade for 4,348 shares valued at $929,620 was made by BILNEY JODY L on Tuesday, March 21. Another trade for 1,500 shares valued at $347,933 was sold by MARGULIS HEIDI S.